Investors purchased shares of Stryker Corporation (NYSE:SYK) on weakness during trading on Monday. $64.94 million flowed into the stock on the tick-up and $30.83 million flowed out of the stock on the tick-down, for a money net flow of $34.11 million into the stock. Of all equities tracked, Stryker had the 24th highest net in-flow for the day. Stryker traded down ($0.37) for the day and closed at $158.23
Several analysts recently weighed in on SYK shares. Robert W. Baird upgraded shares of Stryker from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $161.00 to $173.00 in a report on Thursday, November 16th. JPMorgan Chase & Co. upgraded shares of Stryker from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 2nd. Zacks Investment Research cut shares of Stryker from a “hold” rating to a “sell” rating in a report on Monday, October 16th. BMO Capital Markets upgraded shares of Stryker to a “market perform” rating and set a $163.00 price target on the stock in a report on Tuesday, December 12th. Finally, Stifel Nicolaus lifted their price target on shares of Stryker from $158.00 to $168.00 and gave the company a “buy” rating in a report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. Stryker presently has a consensus rating of “Hold” and an average target price of $156.60.
The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The firm has a market cap of $59,220.00, a PE ratio of 33.74, a P/E/G ratio of 2.27 and a beta of 0.78.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be given a dividend of $0.47 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.88 annualized dividend and a yield of 1.19%. This is a positive change from Stryker’s previous quarterly dividend of $0.43. Stryker’s dividend payout ratio (DPR) is currently 40.09%.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the transaction, the insider now owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 7.40% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of SYK. Acrospire Investment Management LLC purchased a new position in shares of Stryker in the 2nd quarter worth about $111,000. Motco raised its position in Stryker by 50.7% in the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the last quarter. Sawyer & Company Inc purchased a new position in Stryker in the 4th quarter worth about $125,000. Sit Investment Associates Inc. raised its position in Stryker by 114.3% in the 4th quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after buying an additional 440 shares during the last quarter. Finally, San Francisco Sentry Investment Group CA raised its position in Stryker by 47.8% in the 3rd quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after buying an additional 325 shares during the last quarter. 74.88% of the stock is owned by hedge funds and other institutional investors.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.